Erlonat 150mg (Erlotinib)
$225.00
ERLONAT 150MG (ERLOTINIB) is a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC) and advanced pancreatic cancer. It belongs to a class of medications known as EGFR inhibitors, which block the signals that cause cancer cells to multiply. ERLONAT 150MG is typically prescribed for patients whose cancer has specific genetic mutations. Taken orally once daily, this tablet offers a non-invasive option in managing late-stage cancers. It is essential to follow your oncologist’s guidance for best results during Erlotinib cancer treatment.
Quantity
BENEFITS OF ERLONAT TABLET
BENEFITS OF ERLONAT TABLET
In Non-small cell lung cancer
Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Erlonat 150 Tablet helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
SIDE EFFECTS OF ERLONAT TABLET
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Erlonat
- Abdominal pain
- Bone pain
- Breathlessness
- Constipation
- Cough
- Diarrhea
- Fatigue
- Fever
- Infection
- Muscle pain
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weight loss
HOW TO USE ERLONAT TABLET
HOW TO USE ERLONAT TABLET
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Erlonat 150 Tablet is to be taken empty stomach.
HOW ERLONAT TABLET WORKS
Erlonat 150 Tablet is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger, EGFR, hence, inhibits the cancer signaling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells.
SAFETY ADVICE
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Erlonat 150 Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Erlonat 150 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Erlonat 150 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
CONSULT YOUR DOCTOR
It is not known whether Erlonat 150 Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
SAFE IF PRESCRIBED
Erlonat 150 Tablet is safe to use in patients with kidney disease. No dose adjustment of Erlonat 150 Tablet is recommended.
Use of this medicine is not advised in patients with severe kidney disease.
Liver
CAUTION
Erlonat 150 Tablet should be used with caution in patients with liver disease. Dose adjustment of Erlonat 150 Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Erlonat 150 Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
